Aptevo Therapeutics - APVO Net Assets per Single Share

Graphic logo of Aptevo Therapeutics Inc. (APVO)

Aptevo Therapeutics (APVO) generates revenue through the supply of Alphanate for hemophilia and the development of cancer therapies. The company enhances efficiency via bio-screening and computational protein modeling, while management focuses on platform validation. The book value per share history on the GURU.Markets chart demonstrates capital accumulation, with the metric currently standing at 4.23, confirming the business's current volume of net assets.

Aptevo (APVO): Share Book Value from 07/04/2022 to 10/28/2026

Aptevo Therapeutics, Inc. - analytical breakdowns and key metrics (APVO)

- price and consensus price forecast:
Stock Quotes Aptevo|APVO - Price Target Chart
- market capitalization data:
Market Value Aptevo Therapeutics Inc.|APVO - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Aptevo Therapeutics|APVO - Net Asset Value|Market Capitalization to Book Value Ratio aptevotherapeutics.com|APVO - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Aptevo Therapeutics|APVO - Long-Term Debt to Capital|Short-Term Debt to Equity Aptevo|APVO - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Aptevo Therapeutics Inc.
Fundamental company valuation:aptevotherapeutics.com - APVO
Manufactured products of Aptevo

Book value per share determines the portion of net equity attributable to a single common share after deducting all liabilities, allowing for an assessment of the business's intrinsic value. Analysis via the BVPS metric helps determine the extent to which Aptevo Therapeutics (APVO) assets cover its market capitalization during the development of its flagship bispecific antibody programs for targeted oncology therapy.

Competitors of Aptevo Therapeutics (APVO)

ARGX - Accounting Value per Share|BNTX: Net Assets per Single Share|Net Assets per Single Share ABVX|ADMA (admabiologics.com) - Net Asset Value per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Astria Pharma - Book Value per Share|ENGN: Book Value per Share|Net Assets per Single Share RAPT Therapeutics, Inc. (RAPT)|Share Book Value Aerovate Therapeutics|Aclaris Therapeutics, Inc. (ACRS) - Accounting Value per Share|Book Price of a Share Kyverna Therapeutics Inc.|Tiziana Life Sciences PLC - Book Value per Share|Net Asset Value per Share Cabaletta Bio Inc CABA|Accounting Value per Share Ventyx Biosciences VTYX|theratech.com - Net Assets per Single Share|AVTX (Avalo Therapeutics) - Net Assets per Single Share|Eledon Pharmaceuticals Inc. (ELDN) - Net Asset Value per Share|Accounting Value per Share Agenus Inc AGEN|Accounting Value of a Share Climb Bio, Inc|Zura Bio Limited (ZURA) - Accounting Value per Share|Book Price of a Share atyrpharma.com|Adagene (ADAG) - Book Value per Share|Accounting Value of a Share ikenaoncology.com (IMA)|STTK: Book Value per Share|Equillium Inc - Net Asset Value per Share|Net Assets per Single Share Connect Pharma (CNTB)|IMUX - Accounting Value of a Share|ATRA: Book Value per Share|IFRX (InflaRx) - Book Value per Share|Net Assets per Single Share X4 Pharma XFOR|Share Book Value Adicet|Celularity Inc. - Book Value per Share|Net Asset Value per Share inmunebio.com INMB|Accounting Value per Share BRNS (Barinthus Biotherapeutics plc)|KZR - Book Value per Share|Accounting Value per Share SAB Biotherapeutics, Inc SABS|AKTX - Book Price of a Share|enlivex.com - Book Value per Share|Q32 Bio (QTTB) - Net Assets per Share|Book Value per Share GOVX|Accounting Value per Share EDSA|IBIO (iBio Corp) - Net Assets per Single Share|Net Assets per Share carismatx.com (CARM)|Book Value per Share XTLB (XTL Biopharmaceuticals)|Bolt Biotherapeutics Inc. - Book Value per Share|Net Assets per Single Share HCW Biologics Inc|AIM ImmunoTech, Inc. (AIM) - Share Book Value|aditxt.com (ADTX) - Accounting Value per Share|GRI (GRI Bio Corporation) - Net Assets per Single Share|Net Assets per Single Share XRTX (XORTX Therapeutics Inc.)|Net Asset Value per Share HIND|REVB - Net Assets per Single Share|Share Book Value Indaptus Therapeutics Inc (INDP)|Book Value per Share Scinai|Accounting Value of a Share CalciMedica Inc CALI|Affimed Therapeutics - Book Value per Share|ALLK: Book Value per Share|Net Assets per Single Share hookipapharma.com HOOK|IGMS (IGM Biosciences) - Accounting Value of a Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share thirdharmonicbio.com THRD